Concourse Financial Group Securities, Inc. Biotechnology

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
AKRO Akero Therapeutics, Inc.	$1.15B	$0 0.0% of portfolio	0	Q3 2024 New
ALBO Albireo Pharma, Inc.	$0	$0 0.0% of portfolio	0	Q3 2024 New
ALDX Aldeyra Therapeutics, Inc.	$288M	$0 0.0% of portfolio	0	Q3 2024 New
ALEC Alector, Inc.	$149M	$0 0.0% of portfolio	0	Q3 2024 New
ALLK Allakos Inc.	$82.2M	$0 0.0% of portfolio	0	Q3 2024 New
ALLR Allarity Therapeutics, Inc.	$11.4M	$0 0.0% of portfolio	0	Q3 2024 New
ALLO Allogene Therapeutics, Inc.	$296M	$0 0.0% of portfolio	0	Q3 2024 New
ALVR Allovir, Inc.	$40.9M	$0 0.0% of portfolio	0	Q3 2024 New
ALNY Alnylam Pharmaceuticals, Inc.	$29.3B	$0 0.0% of portfolio	3	Q3 2024 Reduced 86.36%
DRTS Alpha Tau Medical Ltd.	$223M	$0 0.0% of portfolio	0	Q3 2024 New
ATHE Alterity Therapeutics LTD	$138M	$0 0.0% of portfolio	0	Q3 2024 New
ALT Altimmune, Inc.	$337M	$0 0.0% of portfolio	100	Q2 2023 New
ALXO Alx Oncology Holdings Inc	$72.1M	$0 0.0% of portfolio	0	Q3 2024 New
FOLD Amicus Therapeutics, Inc.	$2.53B	$0 0.0% of portfolio	0	Q3 2024 New
AMLX Amylyx Pharmaceuticals, Inc.	$205M	$0 0.0% of portfolio	0	Q3 2024 New
ANTX An2 Therapeutics, Inc.	$24.3M	$0 0.0% of portfolio	0	Q3 2024 New
AVXL Anavex Life Sciences Corp.	$875M	$0 0.0% of portfolio	0	Q3 2024 New
ANEB Anebulo Pharmaceuticals, Inc.	$37.4M	$0 0.0% of portfolio	0	Q3 2024 New
ANIX Anixa Biosciences Inc	$69M	$0 0.0% of portfolio	0	Q3 2024 New
ANNX Annexon, Inc.	$230M	$0 0.0% of portfolio	0	Q3 2024 New
ANVS Annovis Bio, Inc.	$39.9M	$0 0.0% of portfolio	0	Q3 2024 New
APLS Apellis Pharmaceuticals, Inc.	$3.01B	$0 0.0% of portfolio	0	Q3 2024 Sold Out
APLT Applied Therapeutics Inc.	$32.7M	$0 0.0% of portfolio	0	Q3 2024 New
APRE Aprea Therapeutics, Inc.	$0	$0 0.0% of portfolio	0	Q3 2024 New
APM Aptorum Group LTD	$17.2M	$0 0.0% of portfolio	0	Q3 2024 New
ABUS Arbutus Biopharma Corp	$493M	$0 0.0% of portfolio	0	Q3 2024 New
ACLX Arcellx, Inc.	$3.02B	$0 0.0% of portfolio	0	Q3 2024 New
ARCT Arcturus Therapeutics Holdings Inc.	$478M	$0 0.0% of portfolio	0	Q3 2024 New
RCUS Arcus Biosciences, Inc.	$1.02B	$0 0.0% of portfolio	0	Q3 2024 New
ARQT Arcutis Biotherapeutics, Inc.	$831M	$0 0.0% of portfolio	0	Q3 2024 New
ARDX Ardelyx, Inc.	$801M	$0 0.0% of portfolio	0	Q3 2024 New
ARGX Argenx Se	$36.3B	$0 0.0% of portfolio	1	Q1 2024 New
ARMP Armata Pharmaceuticals, Inc.	$75.5M	$0 0.0% of portfolio	0	Q3 2024 New
ARWR Arrowhead Pharmaceuticals, Inc.	$1.96B	$0 0.0% of portfolio	0	Q3 2024 New
ARVN Arvinas, Inc.	$991M	$0 0.0% of portfolio	0	Q3 2024 New
ASND Ascendis Pharma A/S	$7.21B	$0 0.0% of portfolio	0	Q3 2024 New
ASLN Aslan Pharmaceuticals LTD	$41.8M	$0 0.0% of portfolio	0	Q3 2024 New
ATXS Astria Therapeutics, Inc.	$118M	$0 0.0% of portfolio	0	Q3 2024 New
ATAI Atai Life Sciences N.V.	$249M	$0 0.0% of portfolio	0	Q3 2024 New
AVIR Atea Pharmaceuticals, Inc.	$272M	$0 0.0% of portfolio	0	Q3 2024 New
ATHA Athira Pharma, Inc.	$21.6M	$0 0.0% of portfolio	0	Q3 2024 New
ATOS Atossa Therapeutics, Inc.	$114M	$0 0.0% of portfolio	0	Q3 2024 New
LIFE A Tyr Pharma Inc	$53.2M	$0 0.0% of portfolio	0	Q3 2024 New
AURA Aura Biosciences, Inc.	$222M	$0 0.0% of portfolio	0	Q3 2024 New
AUPH Aurinia Pharmaceuticals Inc.	$1.15B	$0 0.0% of portfolio	0	Q3 2024 New
AUTL Autolus Therapeutics PLC	$215M	$0 0.0% of portfolio	0	Q3 2024 New
AVEO Aveo Pharmaceuticals, Inc.	$0	$0 0.0% of portfolio	0	Q3 2024 New
CDMO Avid Bioservices, Inc.	$771M	$0 0.0% of portfolio	0	Q3 2024 New
RNA Avidity Biosciences, Inc.	$1.54B	$0 0.0% of portfolio	0	Q3 2024 New
AXSM Axsome Therapeutics, Inc.	$3.43B	$0 0.0% of portfolio	0	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.